Estradiol amplifies interleukin-1-induced monocyte chemotactic protein-1 expression by ectopic endometrial cells of women with endometriosis

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 2, 2000, Pages 896-904

  Akoum, Ali ^a,b,c   Jolicoeur, Christine ^a   Boucher, Annie ^a  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Fonds de la Recherche Santé du Québec   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; INTERLEUKIN 1; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; ENDOMETRIOSIS; ENDOMETRIUM CELL; ESTROGEN ACTIVITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MENSTRUAL CYCLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; RNA SYNTHESIS; RNA TRANSCRIPTION;

ADULT; CELLS, CULTURED; CHEMOKINE CCL2; DRUG SYNERGISM; ENDOMETRIOSIS; ENDOMETRIUM; ESTRADIOL; FEMALE; HUMANS; INTERLEUKIN-1; RNA, MESSENGER; UP-REGULATION;

EID: 0034454707     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.2.896     Document Type: Article

References (50)

1. The epidemiology of endometriosis
2. Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women
3. Endometriosis: Role of ovarian steroids in initiation, maintenance and suppression
4. Is endometriosis an autoimmune disease?
5. Management of endometriosis with gonadotropin-releasing hormone agonists
6. Altered progesterone/estrogen receptor ratios in endometriosis
7. Danazol: Endocrine pharmacology and therapeutic applications
8. Treatment of endometriosis
9. La place de la suppression ovarienne dans le traitement de l'endométriose
10. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial
11. Endometriosis: Abnormal endometrium and dysfunctional immune response
12. Status of current research on endometriosis
13. Immunological aspects of endometriosis
14. Endometrial antibodies in serum and peritoneal fluid of infertile patients with and without endometriosis
15. Interleukin-1: A possible role in the infertility associated with endometriosis
16. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis
17. Classification of endometriotic implants by morphologic appearance and capacity to synthesize prostaglandins
18. Production and secretion of complement component 3 by endometriotic tissue
19. Increased activation of pelvic macrophages in infertile women with mild endometriosis
20. Characterization of leukocyte subpopulations in the peritoneal fluid of women with endometriosis
21. Peritoneal fluid cell populations in infertility patients
22. Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids
23. Peritoneal macrophages from patientes with endometriosis release growth factor activity in vitro
24. Macrophage-conditioned media enhance endometrial stromal cell proliferation in vitro
25. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis
26. Review of peritoneal factors that affect fertility in patients with mild endometriosis
27. Role of peritoneal inflammation in endometriosis-associated infertility
28. Immunolocallzation and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells
29. Secretion of interleukin-6 by endometriotic cells and regulation by inflammatory cytokines and sex steroids
30. Interleukin-6 secretion in vitro is up-regulated in ectopic and eutopic endometrial stromal cells from women with endometriosis
31. Dysregulation of IL-6 responses in ectopic endometrial stromal cells: Correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis
32. Laparoscopic surgery in infertile women with minimal or mild endometriosis
33. Secretion of monocyte chemotactic protein-1 by cytokine-stimulated endometrial cells of women with endometriosis
34. Cytokine-induced secretion of monocyte chemotactic protein-1 by human endometriotic cells in culture
35. Elevated concentration and biological activity of monocyte chemotactic protein-1 in the peritoneal fluid of patients with endometriosis
36. Biology of the RANTES/SIS cytokine family
37. Human monocyte chemoattractant protein-1 (MCP-1)
38. Pathogenesis of endometriosis
39. Revised American Fertility Society classification of endometriosis
40. Increased expression of monocyte chemotactic protein-1 in the endometrium of women with endometriosis
41. Histologic features associated with hormonal responsiveness of ectopic endometrium
42. Stromal-epithelial interactions in adult organs
43. Oestrogen and progesterone receptors in endometriotic tissue and endometrium: Comparison of different cycle phases and ages
44. Immunohistochemical analysis of estrogen and progesterone receptors in endometrium and peritoneal endometriosis: A new quantitative method
45. Peritoneal fluid volume, estrogen, progesterone, prostaglandin, and epidermal growth factor concentrations in patients with and without endometriosis
46. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis
47. Aromatase expression in endometriosis
48. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endometriosis and its modulation of expression in mesothelial cells
49. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene